{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:55:07Z","timestamp":1768517707425,"version":"3.49.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T00:00:00Z","timestamp":1413763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0110344","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T22:08:44Z","timestamp":1413842924000},"page":"e110344","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Hybrid Formulations of Liposomes and Bioadhesive Polymers Improve the Hypotensive Effect of the Melatonin Analogue 5-MCA-NAT in Rabbit Eyes"],"prefix":"10.1371","volume":"9","author":[{"given":"Daniela","family":"Quinteros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Vicario-de-la-Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Andr\u00e9s-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Allemandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Herrero-Vanrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene T.","family":"Molina-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,10,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"A Urtti","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0149-2918(00)88478-7","article-title":"Antiglaucoma medications: a review of safety and tolerability issues related to their use","volume":"22","author":"JS Schuman","year":"2000","journal-title":"Clin Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0275-5408(97)00108-7","article-title":"Glaucoma update: epidemiology and new approaches to medical management","volume":"18","author":"JG Flanagan","year":"1998","journal-title":"Ophthalmic Physiol Opt"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1755-3768.2008.01250.x","article-title":"Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma","volume":"86","author":"C Baudouin","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"C Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"ref6","first-page":"642","article-title":"Quaternary ammoniums and other preservatives\u2019 contribution in oxidative stress and apoptosis on Chang conjunctival cells","volume":"42","author":"C Debbasch","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref7","first-page":"394","article-title":"Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines","volume":"14","author":"E Brasnu","year":"2008","journal-title":"Mol Vis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"EW Leung","year":"2008","journal-title":"J Glaucoma"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","article-title":"Prevalence of and risk factors for dry eye syndrome","volume":"118","author":"SE Moss","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.exer.2006.10.018","article-title":"Melatonin in the eye: implications for glaucoma","volume":"84","author":"PO Lundmark","year":"2007","journal-title":"Exp Eye Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1017\/S0952523801185032","article-title":"Multiple cell targets for melatonin action in Xenopus laevis retina: distribution of melatonin receptor immunoreactivity","volume":"18","author":"AF Wiechmann","year":"2001","journal-title":"Vis Neurosci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.exer.2008.11.004","article-title":"Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT","volume":"88","author":"V Andres-Guerrero","year":"2009","journal-title":"Exp Eye Res"},{"key":"ref13","first-page":"683","article-title":"[Ocular drug absorption by topical route. Role of conjunctiva]","volume":"83","author":"V Andres-Guerrero","year":"2008","journal-title":"Arch Soc Esp Oftalmol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.ijg.0000133150.44686.0b","article-title":"Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes","volume":"13","author":"JB Serle","year":"2004","journal-title":"J Glaucoma"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1167\/iovs.10-6099","article-title":"The Use of Mucoadhesive Polymers to Enhance the Hypotensive Effect of a Melatonin Analogue, 5-MCA-NAT, in Rabbit Eyes","volume":"52","author":"V Andr\u00e9s-Guerrero","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"AD Bangham","year":"1965","journal-title":"Journal of Molecular Biology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-3659(99)00192-3","article-title":"Acyclovir-containing liposomes for potential ocular delivery: Corneal penetration and absorption","volume":"63","author":"SL Law","year":"2000","journal-title":"Journal of Controlled Release"},{"key":"ref18","unstructured":"Vicario-de-la-Torre M, Benitez del Castillo J, Vico E, de las Heras B, Andres V, <etal>et al<\/etal>.. (2010) Formulation based on liposomes and bioadhesive polymers for dry eye treatment. Tolerance studies. Invest Ophthalmol Vis Sci 51: E- Abstract 6275."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"A Ludwig","year":"2005","journal-title":"Advanced Drug Delivery Reviews"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3109\/10717544.2010.483255","article-title":"New method for ophthalmic delivery of azithromycin by poloxamer\/carbopol-based in situ gelling system","volume":"17","author":"F Cao","year":"2010","journal-title":"Drug Deliv"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"AD Bangham","year":"1965","journal-title":"J Mol Biol"},{"key":"ref22","first-page":"395","article-title":"New formulations for dry eye treatment","volume":"82","author":"M Vicario-de-la-Torre","year":"2007","journal-title":"Arch Soc Esp Oftalmol"},{"key":"ref23","unstructured":"Burstein N (1997) Clinical Ocular Pharmacology. Boston: Butterworth-Heinemann. 21\u201345."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1167\/iovs.07-1037","article-title":"Use of poloxamers for deswelling of organ-cultured corneas","volume":"49","author":"M Zhao","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref25","first-page":"252","article-title":"Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation","volume":"7","author":"A Bhatia","year":"2004","journal-title":"J Pharm Pharm Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.ICL.0000141921.80061.17","article-title":"Ocular surface temperature: a review","volume":"31","author":"C Purslow","year":"2005","journal-title":"Eye Contact Lens"},{"key":"ref27","unstructured":"Enr\u00edquez de Salamanca A, Calonge M, Garc\u00eda-Vazquez C, Callejo S, Vila A, <etal>et al<\/etal>.. (2006) Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. 1416\u20131425."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002512-199915050-00005","article-title":"Efficacy and adverse effects of medications used in the treatment of glaucoma","volume":"15","author":"CB Camras","year":"1999","journal-title":"Drugs Aging"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1167\/iovs.10-6338","article-title":"Comparison of the in vitro tolerance and in vivo efficacy of traditional timolol maleate eye drops versus new formulations with bioadhesive polymers","volume":"52","author":"V Andres-Guerrero","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1081\/DDC-120002997","article-title":"Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery","volume":"28","author":"IP Kaur","year":"2002","journal-title":"Drug Dev Ind Pharm"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00061198-200312000-00008","article-title":"Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride","volume":"12","author":"T Ishibashi","year":"2003","journal-title":"J Glaucoma"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ophtha.2006.03.025","article-title":"The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1","volume":"113","author":"JT Whitson","year":"2006","journal-title":"Ophthalmology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1442-9071.2008.01803.x","article-title":"Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells","volume":"36","author":"M Ayaki","year":"2008","journal-title":"Clin Experiment Ophthalmol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1167\/iovs.10-6338","article-title":"Comparison of the in vitro tolerance and in vivo efficacy of traditional timolol maleate eye drops versus new formulations with bioadhesive polymers","volume":"52","author":"V Andres-Guerrero","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref35","unstructured":"Bartlett JD (2012) Ophthalmic Drug Facts: Facts and Comparisons; (Ed.) iH, editor: Lippincott Williams &amp; Wilkins."},{"key":"ref36","unstructured":"Burstein N (1997) Clinical Ocular Pharmacology. Boston: Butterworth-Heinemann."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00137947","article-title":"The viscosity of human tears","volume":"15","author":"JM Tiffany","year":"1991","journal-title":"Int Ophthalmol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4615-2417-5_45","article-title":"Viscoelastic properties of human tears and polymer solutions","volume":"350","author":"JM Tiffany","year":"1994","journal-title":"Adv Exp Med Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/jps.2600630810","article-title":"Ocular evaluation of methylcellulose vehicle in albino rabbits","volume":"63","author":"SS Chrai","year":"1974","journal-title":"J Pharm Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/jps.2600640811","article-title":"Ocular evaluation of polyvinyl alcohol vehicle in rabbits","volume":"64","author":"TF Patton","year":"1975","journal-title":"J Pharm Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"G Dumortier","year":"2006","journal-title":"Pharm Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1021\/bm0055798","article-title":"Rheology of sodium hyaluronate under physiological conditions","volume":"2","author":"WE Krause","year":"2001","journal-title":"Biomacromolecules"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic drug delivery systems\u2013Recent advances","volume":"17","author":"C Le Bourlais","year":"1998","journal-title":"Progress in Retinal and Eye Research"},{"key":"ref44","first-page":"2765","article-title":"Topical application of a cyclic GMP analog lowers IOP in normal and ocular hypertensive rabbits","volume":"35","author":"PJ Stein","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2012.12.009","article-title":"Melatonin analogue agomelatine reduces rabbit\u2019s intraocular pressure in normotensive and hypertensive conditions","volume":"701","author":"A Martinez-Aguila","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.2042-7158.1996.tb03977.x","article-title":"The preparation of norfloxacin-loaded liposomes and their in-vitro evaluation in pig\u2019s eye","volume":"48","author":"HH Lin","year":"1996","journal-title":"J Pharm Pharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1167\/iovs.05-1345","article-title":"Effect of subconjunctivally injected, liposome-bound, low-molecular-weight heparin on the absorption rate of subconjunctival hemorrhage in rabbits","volume":"47","author":"JW Moon","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2005.04.029","article-title":"Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method","volume":"298","author":"T Nii","year":"2005","journal-title":"Int J Pharm"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bjo.72.9.688","article-title":"Pharmacokinetics of a 5-fluorouracil liposomal delivery system","volume":"72","author":"ST Simmons","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0031-6865(95)00010-7","article-title":"Preparation and characterization of liposomes as therapeutic delivery systems: a review","volume":"70","author":"S Vemuri","year":"1995","journal-title":"Pharm Acta Helv Jul"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0110344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T11:15:09Z","timestamp":1565954109000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0110344"}},"subtitle":[],"editor":[{"given":"Ted S.","family":"Acott","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,20]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0110344","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,20]]}}}